REFERENCES
- Mínguez F, Chiu ML, Prieto J. Efecto postantifúngico. Rev Esp Quimioterap 1993; 6: 33–5.
- Mínguez F, García MT, Lima JE, Llorente MT, Prieto J. Postantifungal effect and effects of low concentrations of Amphotericin B and Fluconazole on previously treated Candida albicans. Scand J Infect Dis 1996; 28: 503–6.
- Troke PF, Marriot MS, Richardson K, Tarbit MH. In vitro and in vivo activity of azoles. Ann NY Acad Sci 1988; 544: 284–93.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution susceptibility testing of yeasts. Proposed standard Document M27-P. Villanova, Spain: National Committee for Clinical Laboratory Standards; 1992.
- Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V, ed. Antibiotics in laboratory medicine, 3rd edn. Baltimore, MD: Williams & Wilkins, 1991: 403–31.
- Kikuchi K, Enari T, Minami S, et al. Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis. J Antimicrob Chemother 1994; 34: 687–96.
- Turnidge JD, Gudmundsson S, Vogelman B, Craig WA. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J Antimicrob Chemother 1994; 34: 83–92.
- Mínguez F, Lima JE, García MT, Prieto J. Influence of human serum on the postantifungal effect of four antifungal agents on C. albicans. Chemotherapy 1996; 42: 273–9.
- Odenholt I. Studies on the postantibiotic effect and the postantibiotic subMIC effect of meropenem. J Antimicrob Chemother 1993; 31: 881–92.
- Odenholt I, Löwdin E, Cars O. Postantibiotic subMIC effects of vancomycin, roxithromycin, sparfloxacin and amikacin. Antimicrob Agents Chemother 1992; 36: 1852–8.
- Bryant RE. Effect of the supply antibiotic activity. In: R.k., editor. Contemporary issues in infectious dimensions in antimicrobial therapy. New York: 1984: 313–37.
- Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases, 3rd edn. New York: Churchill Livingstone, 1990: 582–611.
- Yamamoto T, Nohara K, Uchida K, Yamaguchi H. Purification and characterization of secretory proteinase of Candida albicans. Microbiol Immunol 1992; 36: 637–41.
- Stewart E, Gow NA, Bowen DV. Cytoplasmic alkalinization during germ tube formation in Candida albicans. J Gen Microbiol 1988; 134: 1079–87.
- Suzuki S. Immunochemical study on mannan, the antigenic polysaccharide of pathogenic yeasts in man of genus Candida. Yakugaku Zasshi 1995; 115: 280–94.
- Xiong YQ, Caillon J, Drugeon H, Potel G, Baron D. Influence of pH on adaptative resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects. Antimicrob Agents Chemother 1996; 40: 35–9.
- Zhanel GG, Karlowsky JA, Davidson RJ, Hoban DJ. Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli. Chemotherapy 1991; 37: 218–23.
- Gudmundsson A, Erlensdottir H, Gottfredsson M, Gudmundsson S. Impact of pH and cationic supplementation on in vitro postantibiotic effect. Antimicrob Agents Chemother 1991; 35: 2617–24.
- Newton DW, Kluza RB. pK of compounds in pharmacy practice. Drug 1978; 12: 546–54.
- Diasio RB, Lakings DE, Bennett JE. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans. Possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother 1978; 14: 903–8.
- Boiron P, Drouhet E, Dupont B, Improvisi L. Entry of ketoconazole into C. albicans. Antimicrob Agents Chemother 1987; 31: 244–8.